Ligand Pharmaceuticals Incorporated

États‑Unis d’Amérique


 
Quantité totale PI 120
Quantité totale incluant filiales 415 (+ 295 pour les filiales)
Rang # Quantité totale PI 10 845
Note d'activité PI 2,5/5.0    44
Rang # Activité PI 16 773
Activité incl filiales 2,6/5.0    136
Symbole boursier
ISIN US53220K5048
Capitalisation 2,400M  (USD)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

46 10
6 4
47 6
1
 
Dernier brevet 2024 - Unnatural configuration nucleoti...
Premier brevet 1992 - Use of selective ligands for tre...
Dernière marque 2025 - BEPRO
Première marque 1995 - LIGAND

Filiales

9 subsidiaries with IP (257 patents, 38 trademarks)

2 subsidiaries without IP

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Pharmaceutical research and development
2024 P/S Pharmaceutical research and development. Licensing of pharmaceutical products.
P/S Solubilizing chemical agents for use in the manufacture of pharmaceutical preparations; solubili...
P/S Solubilizing chemical agents for use in the manufacture of pharmaceutical preparations; Solubiliz...
2022 Invention Cyclic phosphoramidate compounds. Provided herein are cyclic phosphoramidate compounds, their pre...
Invention Nucleotide prodrug compounds. Provided herein are nucleotide prodrug compounds, their preparation...
Invention Unnatural configuration nucleotide prodrug compounds. Provided herein am phosphoramidate and cyc...
Invention Unnatural configuration nucleotide prodrug compounds. Provided herein are phosphoramidate and cyc...
P/S Pharmaceutical research and development of a process to deliver pharmaceutical preparations.
2021 Invention Heterocycle amines and uses thereof. Compounds and methods in the fields of chemistry and medicin...
Invention Antiviral prodrug compounds. Provided herein are nucleotide prodrug compounds, their preparation...
Invention Antiviral prodrug compounds. Provided herein are nucleotide prodrug compounds, their preparation ...
P/S Pharmaceutical research and development of a process to deliver pharmaceutical preparations
P/S Pharmaceutical research and development Licensing of pharmaceutical products
Invention Benzyloxy phosph(on)ate compounds. Provided herein are 2-substituted benzyloxy phosph(on)ate com...
Invention Benzyloxy phosph(on)ate compounds. Provided herein are 2-substituted benzyloxy phosph(on)ate comp...
2020 Invention Imidazo-fused heterocycles and uses thereof. Compounds and methods in the fields of chemistry and...
Invention Selective androgen receptor modulators (sarms) and uses thereof. Provided herein are compounds, s...
Invention Methods and compositions associated with the granulocyte colony-stimulating factor receptor. Some...
Invention Cyclic phosphate compounds. Provided herein are cyclic phosphate compounds, their preparation an...
Invention Cyclic phosphate compounds. Provided herein are cyclic phosphate compounds, their preparation and...
Invention Crystalline forms and methods of producing crystalline forms of a compound. Disclosed herein are...
Invention Crystalline forms and methods of producing crystalline forms of a compound. Disclosed herein are ...
2019 P/S Pharmaceutical research and development of a process to deliver organ specific pharmaceutical pre...
P/S Pharmaceutical research and development of a process to deliver organ specific pharmaceutical pr...
Invention Methods and compositions for modulating hormone levels. Provided herein are compositions and meth...
Invention Prodrug compounds and their uses. Provided herein are prodrug compounds, their preparation and th...
Invention Glucagon receptor antagonists. Provided herein are solid state forms of compounds, including enan...
Invention Acetal compounds and therapeutic uses thereof. Disclosed herein are acetal and cyclic acetal comp...
2018 Invention Glucagon antagonists. Provided herein are compounds, including enantiomerically pure forms there...
Invention Prodrug compounds and uses thereof. Provided herein are cyclic phosphorus-containing prodrug comp...
Invention Method for treating chronic inflammatory diseases. Methods of administering and pharmaceutical c...
Invention Methods of treatment associated with the granulocyte colony-stimulating factor receptor. Some emb...
2017 Invention Method for treating disorders associated with glomerular function. Methods of administering and p...
Invention Glucagon receptor antagonists. Provided herein are compounds, including enantiomerically pure fo...
Invention Glucagon receptor antagonists. Provided herein are compounds, including enantiomerically pure for...
Invention Derivatives of uridine 5′-cyclophosphate useful to treat hepatitis c viral infections. Some embod...
2016 P/S Licensing of pharmaceutical products
Invention Gemcitabine derivatives. Compositions and methods in the field of medicine and chemistry are disc...
2015 Invention Prodrug compounds and uses therof. Provided herein are cyclic phosphorus-containing prodrug compo...
Invention Glucagon antagonists. Provided herein are compounds, including enantiomerically pure forms thereo...
2001 P/S Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use...
1995 P/S Medicines for the treatment of cancer conditions. Medicines for the treatment of cancer and pre-c...